Most Newer Antipsychotics No Better Than Older Ones, Just Different

Related Encyclopedia • Autism • Bipolar Disorder • Death and Grieving • Dementia More... Related Healthscout Videos Pinpointing Mental Illness Body Dysmorphic Disorder- A Serious Disease Meet Sue Bergeson Getting a Second Opinion More... Related Animations • Schizophrenia and the Brain More... Related Drug Information • Adderal XR • Concerta • Effexor XR • Paxil More... Related News Articles • Binge Drinking Not Just a Rite of the Young • Working Intensely Early on May Help Autistic Kids • Study: TV Time Doubled in Home Daycares • Cancer Patients Struggle with Insomnia More...

Page:  << Prev | 1 | 2 | 3

Dr. Thomas R. Insel, director of the U.S. National Institute of Mental Health, believes efforts are needed to find ways to tell which patients will respond to which of the many drugs available.

"Neither class of drugs is homogenous," Insel said. "There is not a huge difference between the classes when you look at efficacy. Where the differences emerge is largely with side effects."

"It would be wonderful," he added, "if we could know how to predict which patient is going to respond to which medication, but we don't know that yet. But we do know that just because somebody doesn't respond to the first one doesn't mean they are not going to respond to the next one."

Text Continues Below

---

Finding "biomarkers" that would predict which drug will work for a given patient is going to be the focus of new research, Insel said. "We really need to get serious about personalized medicine for psychiatric illnesses," he said.

More information

To learn more about antipsychotic drugs, visit the U.S. National Institute of Mental Health.

Page:  << Prev | 1 | 2 | 3